Featured Expert

• Ajay Vora, MD, FRCP, FRCPath, Great Ormond Street Hospital, London, United Kingdom
  University of Sheffield, Sheffield, United Kingdom

Featured Topic

There is only one first time: Making the most of initial therapy for pediatric ALL

Learning Objective

• Select an appropriate first-line treatment strategy for pediatric patients with ALL based on recent clinical trial data and expert recommendations, including considerations for “pediatric-inspired” therapy for adolescent patients.

Featured Expert

• Martin Schrappe, MD, PhD, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany

Featured Topic

How do you measure success in ALL?: Assessment of MRD

Learning Objective

• Describe the importance of eliminating minimal residual disease and the role it plays in treatment selection throughout the management of ALL.

Featured Expert

• Shai Izraeli, MD, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel

Featured Topic

Strategic decisions for relapsed ALL: How and when to incorporate novel agents

Learning Objective

• Identify an effective treatment approach for patients with relapsed/refractory ALL, including considerations for reinduction, prognostic factors, and incorporation of emerging therapies.

Featured Expert

• Shai Izraeli, MD, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel

Featured Topic

Conclusion and prIME Points